Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Wanwei Pharmaceutical is a prominent pharmaceutical distribution and service company based in Beijing, China. It gained international recognition in 2005 as the first Chinese pharmaceutical distribution firm to be acquired by a foreign entity when Beijing Med-Pharm Corp. (later BMP Sunstone) purchased it following WTO-related legal reforms. The company operates an extensive hospital sales network, covering over 90% of Beijing's hospitals and providing end-to-end solutions including clinical trial management, registration, and marketing for international pharmaceutical firms. Following the acquisition of BMP Sunstone by Sanofi in 2011, Wanwei's operations were integrated into Sanofi's broader presence in the Chinese healthcare market. Historically, the company has held exclusive distribution and promotional rights for various products in therapeutic areas such as gynecology, pediatrics, and obstetrics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Wanwei Pharmaceutical.